Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hey, good morning. Today, we see CBER suspend the license for a chikungunya vaccine, look at a push to recall a safety and efficacy study for the antidepressant Paxil, and more. FDA pulls license for chikungunya vaccine The Food and …
Read More »Readout Newsletter: FDA, Paxil, chikungunya, GSK
